$11.5 Billion Worldwide Hormone Replacement Therapy Industry to 2027 – Featuring Abbott Laboratories, Bayer, Eli Lilly & Company and Roche Among Others – ResearchAndMarkets.com

$11.5 Billion Worldwide Hormone Replacement Therapy Industry to 2027 – Featuring Abbott Laboratories, Bayer, Eli Lilly & Company and Roche Among Others – ResearchAndMarkets.com




$11.5 Billion Worldwide Hormone Replacement Therapy Industry to 2027 – Featuring Abbott Laboratories, Bayer, Eli Lilly & Company and Roche Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Hormone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

The global hormone replacement therapy market size reached US$ 8.1 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 11.5 Billion by 2027, exhibiting a CAGR of 6.02% during 2021-2027.

Companies Mentioned

  • Abbott Laboratories
  • Bayer AG
  • Eli Lilly & Company
  • Roche
  • Hisamitsu Pharmaceutical Co. Inc.
  • Merck
  • Mylan
  • Novartis
  • Novo Nordisk
  • Pfizer

Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Hormone replacement therapy (HRT) is used for replenishing the hormones that are present in low levels in the human body. This treatment is particularly favourable for patients with growth hormone deficiency, women nearing menopause and elderly people suffering from hypogonadism. HRT is available in several forms such as skin and mouth patches (transdermal), gels, injections and implants.

However, HRT may not be suitable for patients who have a history of blood clots, liver disease and untreated high blood pressure. This therapy may also include some adverse effects like bloating, swelling, nausea, leg cramps, headaches, indigestion, increased cholesterol levels and a rise in the number of red blood cells.

A surge in the incidences of hormone imbalance disorders in the geriatric and neonatal populations is primarily driving the market growth. The rising need for new treatment options with better safety results is further boosting the demand for (HRT) hormone replacement therapy.

Additionally, aggressive marketing and direct selling campaigns by the key players along with the development of new gel-based formulations creates an attractive market for these therapies. Moreover, increasing awareness among the consumers and the presence of regularly monitored formulations are some of the other drivers stimulating the growth of the market.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global hormone replacement therapy market report, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on product, route of administration and type of disease.

Breakup by Product:

  • Estrogen Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy
  • Testosterone Replacement Therapy
  • Others

Based on product, estrogen replacement therapy accounts for the majority of the market share. Other types include human growth hormone replacement therapy, testosterone replacement therapy, thyroid replacement therapy and others.

Breakup by Route of Administration:

  • Oral
  • Parenteral
  • Transdermal

On the basis of route of administration, the report has segmented the market on the basis of oral, parenteral and transdermal segments.

Breakup by Type of Disease:

  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others

On the basis of disease, the report has segmented the market on the basis of menopause, hypothyroidism, male hypogonadism, growth hormone deficiency and others.

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the largest market, accounting for the majority of the market share.

Key Questions Answered in This Report

1. What will be the global hormone replacement therapy market outlook during the forecast period (2022-2027)?

2. What are the global hormone replacement therapy market drivers?

3. What are the major trends in the global hormone replacement therapy market?

4. What is the impact of COVID-19 on the global hormone replacement therapy market?

5. What is the global hormone replacement therapy market breakup by product?

6. What is the global hormone replacement therapy market breakup by route of administration?

7. What is the global hormone replacement therapy market breakup by type of disease?

8. What are the major regions in the global hormone replacement therapy market?

For more information about this report visit https://www.researchandmarkets.com/r/4wjt1a

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900